Biotech · Private company
Alentis Therapeutics AG
Track this companyFree. Adds Alentis Therapeutics AG to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- ALE.C04Phase 2 · Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- ALE.P02Phase 2 · Squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ALE.P03Phase 2 · Cervical Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ALE.F02Phase 1 · Advanced Liver FibrosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsPHASE1_PHASE2 · RECRUITING · started Aug 26, 2025ClinicalTrials.gov NCT07169734 · fetched Nov 12, 2026
- A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid TumorsPHASE1_PHASE2 · RECRUITING · started Dec 16, 2024ClinicalTrials.gov NCT06747585 · fetched Nov 12, 2026
- Study of ALE.C04 in Patients With Head and Neck CancerPHASE1_PHASE2 · TERMINATED · started Oct 30, 2023ClinicalTrials.gov NCT06054477 · fetched Nov 12, 2026
- A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild CirrhosisPHASE1 · COMPLETED · started Apr 1, 2023ClinicalTrials.gov NCT05939947 · fetched Nov 12, 2026